NetworkNewsBreaks – Lexaria Bioscience Corp. (CS
Post# of 721
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced its entry into a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp. Under the agreement, Lexaria will provide its patented DehydraTECH(TM) technology to a private Nevada-based company for utilization in certain CBD-based beverages that will be produced and sold across the U.S. Lexaria continues to experience strong demand for use of its technology for beverage applications in North American markets. Lexaria’s many existing US-granted patents protect DehydraTECH-enabled products, which may include any combination of ready-to-drink beverages such as non-alcoholic beers, wines and spirits, cold or hot coffee or teas, sports drinks and more.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer